Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why

15d ago, source: Hosted on MSN

Praxis Precision Medicines, Inc. (PRAX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in ...

Praxis Precision Medicines gets grant for treatment of neurological disorders with fused heteroaryl compounds

3d ago, source: Pharmaceutical Technology

Discover how Praxis Precision Medicines Inc's patented fused heteroaryl compounds are revolutionizing the treatment of epilepsy and neurological disorders. Explore the groundbreaking method outlined ...

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)

13h ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Hookipa Pharma (HOOK – Research Report), ...

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology ...

14d ago, source: The Bakersfield Californian

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies ...

Stocks Give Up Early Gains as Nvidia Weighs on Chip Stocks

1mon ago, source:

Detailed price information for International Paper Company (IP-N) from The Globe and Mail including charting and trades.

Why an ALS Drug Was Pulled From the Market

9d ago, source: MedPage Today

DENVER -- Topline data presented here showed why Amylyx Pharmaceuticals decided to remove its amyotrophic lateral sclerosis ...

SAGE Therapeutics: Hold Rating Amidst Zurzuvae Success and Dalzanemdor Setbacks

10h ago, source:

In a report released today, Douglas Tsao from H.C. Wainwright maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report), ...

PathAI gets grant for validating performance of a trained model for pathology images

3d ago, source: Pharmaceutical Technology

Validate the performance of trained models predicting tissue characteristics with PathAI Inc's patented method. Enhance accuracy and reliability in pathology image analysis.

Clarified Precision Medicine Raises $1.2M in Seed Round

10d ago, source: precisionmedicineonline

The firm will use the funds to further commercialize its virtual molecular tumor board platform and broaden access to precision oncology expertise.

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting

14d ago, source: Yahoo Finance

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage ...